Medication info
Tenaglin Duo Sustained Release Tablet 20/1000 mg

Tenaglin Duo Sustained Release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Pink oval sustained-release film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202201438 · Approved 2022.04.04 · Insurance code 650304320

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar in patients with type 2 diabetes. It is particularly suitable for patients taking both teneligliptin and metformin, assisting in dietary and exercise management. This helps achieve better blood sugar control. In other words, this medication aids in improving blood sugar management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication helps control blood sugar; however, there are several important cautionary points to consider when using it. First, this medication should not be administered to patients with poor kidney function. It can be dangerous for those with moderate or severe renal impairment to take this medication. Second, it should not be used by patients with heart disease, severe infections, or liver dysfunction, as this could be harmful. Third, this medication should be discontinued before any imaging tests utilizing iodine contrast agents and should only be resumed after confirming normal kidney function post-examination. Fourth, women who are pregnant or may become pregnant should not take this medication, and breastfeeding mothers should decide whether to take it in consultation with their doctor. Fifth, the risk of hypoglycemia may increase if this medication is taken together with other diabetes drugs, so patients should be well-informed about hypoglycemic symptoms and respond immediately if symptoms occur. Sixth, alcohol consumption should be avoided while taking this medication as it may enhance the risk of side effects. Seventh, this medication can rarely cause a dangerous condition known as lactic acidosis; therefore, if symptoms such as sudden muscle pain, breathing difficulties, weakness, or abdominal pain occur, medical attention should be sought immediately. Eighth, elderly patients are likely to have impaired kidney function, so regular kidney function tests are necessary, and dosage adjustments may be needed. Ninth, during treatment with this medication, it is important to regularly check kidney function and vitamin B12 levels through blood tests. Finally, if any unusual symptoms appear during the course of treatment with this medication, consultation with a doctor should be obtained immediately, especially if there are skin blisters or severe abdominal pain, and immediate treatment should be sought.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • autoimmune bullous dermatosis
  • acute pancreatitis
  • dizziness
  • constipation
  • abdominal distension
Show 111 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • elevated serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision impairment
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis of the spine
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculus
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • dizziness
  • iron deficiency anemia
  • food allergy
  • foot fracture
  • diarrhea
  • nausea
  • vomiting
  • decreased serum vitamin B12
  • severe arthralgia
  • vesicular autoimmune bullous dermatosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Pink oval sustained-release film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.